FDA approves 100th monoclonal antibody product

Thirty-five years on from the FDA's approval of a first monoclonal antibody, these biologics account for nearly a fifth of the agency's new drug approvals each year. Thirty-five years on from the FDA's approval of a first monoclonal antibody, these biologics account for nearly a fifth of the agency's new drug approvals each year.

Automated summary

After 35 years since the FDA approved the first monoclonal antibody, these biologics now make up nearly one fifth of the agency's new drug approvals each year.